ctrl K

Watchlist Price Alert

Ikena Oncology Inc. (IKNA)

NASDAQ: IKNA · Real-Time Price · USD

1.36

-0.05 (-3.55%)

At close: Jun 17, 2025, 2:21 PM

Ikena Oncology Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	9.16M	15.62M	30.98M	9.19M	13.75M	990K
Cost of Revenue	n/a	1.02M	2.03M	47.11M	44.85M	24.94M	38.99M
Gross Profit	n/a	8.14M	13.58M	-16.12M	-35.65M	-11.19M	-38M
Operating Income	-58.97M	-75.42M	-70.9M	-34.14M	-44.52M	-18.49M	-40.89M
Interest Income	n/a	7.11M	2.15M	23K	n/a	n/a	n/a
Pretax Income	-49.08M	-68.33M	-68.77M	-34.12M	-44.26M	-16.82M	-40.87M
Net Income	-49.23M	-68.17M	-66.63M	-34.12M	-44.26M	-16.82M	-40.87M
Selling & General & Admin	23.68M	24.93M	22.2M	18.02M	8.87M	7.31M	2.9M
Research & Development	30.39M	59.65M	64.32M	47.11M	44.85M	24.94M	38.56M
Other Expenses	4.42M	n/a	-10K	23K	263K	1.68M	n/a
Operating Expenses	58.97M	84.58M	86.52M	65.12M	53.71M	32.24M	41.46M
Interest Expense	n/a	n/a	2.15M	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	84.58M	86.52M	65.12M	53.71M	32.24M	41.88M
Income Tax Expense	152K	-162K	-2.14M	307.44K	93.7K	71.14K	n/a
Shares Outstanding (Basic)	48.26M	41.74M	36.19M	35.98M	35.85M	35.85M	35.85M
Shares Outstanding (Diluted)	48.26M	41.74M	36.19M	35.98M	35.85M	35.85M	35.85M
EPS (Basic)	-1.02	-1.63	-1.84	-0.95	-1.23	-0.47	-1.14
EPS (Diluted)	-1.02	-1.63	-1.84	-0.95	-1.23	-0.47	-1.14
EBITDA	-48.59M	-74.4M	-70.15M	-33.59M	-44.22M	-18.25M	-40.44M
EBIT	-49.08M	-75.42M	-70.9M	-34.14M	-44.52M	-18.49M	-40.87M
Depreciation & Amortization	490K	1.02M	2.03M	1.72M	1.26M	122K	422K